Clinical Study
Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection
Table 1
Patient characteristics at time of initiation of RLAI.
| Variable | | Mean |
| Age (years) | 177 | 47.1 (SD 13.6) Range 22–84 | Female (%) | 177 | 92 (52.0%) | Disease duration | | | Years | 137* | 15.3 (SD 12.5) | % less than 4 years | 137* | 31 (17.5%) | % 4 to 10 years | 137* | 44 (24.8%) | % more than 10 years | 137* | 102 (57.7%) | GAF (raw score) | 21* | 22.5 (SD 13.9) Range 5–60 | GAS (raw score) | 49* | 35.2 (SD 9.6) Range 19–58 | CGI-S (%) | | | Normal | 177 | 0 | Borderline or mildly Ill | 177 | 1 (0.6%) | Moderately Ill | 177 | 2 (1.1%) | Markedly Ill | 177 | 16 (9.0%) | Severely or among most extensively Ill | 177 | 8 (4.5%) | Unknown | 177 | 150 (84.7%) | Occupational status (%) | | | Full time | 177 | 2 (1.1%) | Part time | 177 | 0 | Sheltered work | 177 | 1 (0.6%) | Unemployed | 177 | 13 (7.3%) | Retired | 177 | 121 (68.4%) | Long-term sick leave | 177 | 33 (18.7%) | Other | 177 | 7 (4.0%) | Unknown | 177 | 0 | Accommodation status (%) | | | Psychiatric nursing home | 177 | 15 (8.5%) | Sheltered living | 177 | 5 (2.8%) | With parents or relatives | 177 | 20 (11.3%) | Own apartment | 177 | 125 (70.6%) | Other | 177 | 12 (6.8%) | Unknown | 177 | 0 |
|
|
*Missing information resulted in reduced sample sizes.
|